ERYTECH Strengthens Executive Leadership Team with Appointments of Chief Scientific Officer and Chief Business Officer

Post author:admERY
Post published:October 27, 2016
Post category:Newsroom

ERYTECH today announced the appointments of Dr. Alexander Scheer, Ph.D. as the company’s Chief Scientific Officer and Jean-Sébastien Cleiftie, as Chief Business Officer.

You Might Also Like

ERYTECH Reports Determination of the Recommended Pivotal Phase 3 Dose of eryaspase in its U.S. Phase 1 Study in First Line Adult ALL

ERYTECH announces management change

ERYTECH to Present Novel Vesiculation Approach at the 24th Meeting of the European Red Cell Society